Crypto Briefing·
Iambic Therapeutics jumps 16% in Nasdaq debut after $150M IPO
Iambic's successful IPO highlights growing investor confidence in AI-driven biotech, potentially accelerating innovation in cancer treatment.
More news
- The DefiantRussia Bars Self-Custody Withdrawals From Regulated Crypto Accounts
- Crypto BriefingAdobe expands Nvidia collaboration to bring Nemotron to Brand Concierge
- Crypto BriefingCitigroup projects tokenized assets could reach $5.5T by 2030
- Finance MagnatesRipple Prime Connects Institutions to Hyperliquid’s 24/7 Markets Through Swaps
- CryptoSlateTrump’s crypto bill loses its White House negotiator as Patrick Witt exits
- ForkastMuse’s 2M Users Choose Tasks Over Home Control